Drug Type ASO |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization Hybridize TherapeuticsStartup |
Active Organization Hybridize TherapeuticsStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Preclinical | NL | Hybridize TherapeuticsStartup | 30 Nov 2022 |
Nephritis | Preclinical | NL | Hybridize TherapeuticsStartup | 30 Nov 2022 |